Compare · DXCM vs SSII
DXCM vs SSII
Side-by-side comparison of DexCom Inc. (DXCM) and SS Innovations International Inc. (SSII): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both DXCM and SSII operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- DXCM is the larger of the two at $31.89B, about 48.2x SSII ($661.3M).
- DXCM has been more active in the news (12 items in the past 4 weeks vs 4 for SSII).
- DXCM has more recent analyst coverage (25 ratings vs 0 for SSII).
- Company
- DexCom Inc.
- SS Innovations International Inc.
- Price
- -
- -
- Market cap
- $31.89B
- $661.3M
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2005
- News (4w)
- 12
- 4
- Recent ratings
- 25
- 0
DexCom Inc.
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company offers its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM system for diabetes management; Dexcom G7, a next generation G7 CGM system; and Dexcom Share, a remote monitoring system. DexCom, Inc. has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop next-generation CGM products. The company markets its products directly to endocrinologists, physicians, and diabetes educators. DexCom, Inc. was founded in 1999 and is headquartered in San Diego, California.
Latest DXCM
- Director Boehnlein Glenn S was granted 5,841 shares (SEC Form 4)
- New insider Boehnlein Glenn S claimed ownership of 42 shares (SEC Form 3)
- DexCom Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits
- Dexcom Appoints Glenn Boehnlein to Board of Directors
- Dexcom Announces Upcoming Conference Presentation
- EVP Chief People & Culture Off Stern Sadie sold $226,669 worth of shares (2,565 units at $88.37) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 126,043 units (SEC Form 4)
- EVP Chief Legal Compliance Off Brown Michael Jon covered exercise/tax liability with 1,451 shares, decreasing direct ownership by 1% to 101,502 units (SEC Form 4) (withholding obligation)
- EVP, Chief Financal Officer Sylvain Jereme M covered exercise/tax liability with 1,451 shares, decreasing direct ownership by 0.96% to 150,390 units (SEC Form 4) (withholding tax)
- President, CEO, and Director Leach Jacob Steven covered exercise/tax liability with 1,451 shares, decreasing direct ownership by 0.35% to 418,908 units (SEC Form 4) to satisfy withholding tax
- EVP Chief People & Culture Off Stern Sadie covered exercise/tax liability with 1,451 shares, decreasing direct ownership by 1% to 128,608 units (SEC Form 4) (withholding tax)
Latest SSII
- SS Innovations International Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- SS Innovations Provides Update on Continuing Progress and Milestones
- Chairman and CEO Sudhir Srivastava sold $99,999 worth of shares (33,333 units at $3.00) (SEC Form 4)
- SS Innovations International Inc. filed SEC Form 8-K: Leadership Update
- SS Innovations International Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits
- SS Innovations Reports Second Quarter 2026 Financial Results
- SEC Form 10-Q filed by SS Innovations International Inc.
- SEC Form 3 filed by new insider Romano Sarah
- SS Innovations International Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- SS Innovations To Showcase the SSi Mantra Surgical Robotic System at SRS 2026